A first-in-man trial of NPM-115 for chronic weight management in obese or overweight patients
Latest Information Update: 02 Apr 2024
At a glance
- Drugs Exenatide (Primary)
- Indications Obesity
- Focus Adverse reactions; First in man
Most Recent Events
- 02 Apr 2024 New trial record
- 26 Mar 2024 Accoeding to Vivani Medical media release, the company plans to submit a new Investigational New Drug Application for NPM-115 in second half of 2024 and initiating a first-in-man trial after receiving regulatory clearance to proceed.